Recall: Accupril Tablets
May 2022Pharmacy Updates
Pfizer is recalling batches of Accupril tablets (Quinapril HCl – 10 mg, 20 mg, and 40 mg) due to the presence of a nitrosamine, Nnitrosoquinapril, that was observed in recent testing at levels above the Acceptable Daily Intake (ADI) level. Read the full text of the Accupril Tablets recall.
Recent Announcements
UPMC Dental Advantage celebrates 15-years of growth
From pilot program to now serving all product linesJan. 2026What's New
Provider Directory Updates and Required Attestation
As you know, UPMC Health Plan requires all providers to verify their provider directory information at least every 90 days (quarterly).Jan. 2026Important Notices
Important: Expedited appeals fax requirement
Please remember that you must adhere to the designated process for submitting expedited appeals to have them processed in a timely manner. Follow these guidelines to help you successfully submit expedited appeals:Jan. 2026Important Notices